Galapagos | GLPG - Loan Capital

Stock Price
25.60
Daily Change
-0.34 -1.31%
Monthly
-9.86%
Yearly
15.94%
Q2 Forecast
24.72

Galapagos reported EUR5.19M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Genmab DKK 5.14B 5.01B Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 8.47B 624.81M Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Merck EUR 10.73B 277M Dec/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 29.59B 5.35B Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.18B 634M Dec/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025